Dilution screener
Every company we cover, scored for dilution risk from its SEC filings. Browse all tickers A to Z
 Lantronix, Inc. | $5.89 | $276.58M | Pro | Pro |
 Powerus Corp. | $1.68 | $275.25M | Pro | Pro |
 Alico, Inc. | $36.96 | $274.27M | Pro | Pro |
 Alto Ingredients, Inc. | $3.54 | $274.21M | Pro | Pro |
 Outdoor Holding Company | $2.36 | $273.32M | Pro | Pro |
 Ranpak Holdings Corp. | $3.19 | $273.23M | Pro | Pro |
 Silvia, Inc. | $2.94 | $273.06M | Pro | Pro |
 BioAge Labs Inc. | $5.93 | $271.94M | Pro | Pro |
 Electrovaya Inc. | $5.36 | $267.49M | Pro | Pro |
 Aurora Cannabis Inc. | $5.11 | $267.17M | Pro | Pro |
 NACCO Industries, Inc. | $34.99 | $264.32M | Pro | Pro |
 Lyell Immunopharma, Inc. | $10.77 | $263.92M | Pro | Pro |
 Ultralife Corporation | $15.62 | $260.3M | Pro | Pro |
 Larimar Therapeutics, Inc. | $2.50 | $260.23M | Pro | Pro |
 Q32 Bio Inc. | $8.74 | $259.59M | Pro | Pro |
 Lotus Technology Inc. American Depositary Shares | $0.335 | $259.32M | Pro | Pro |
 Aviat Networks, Inc. | $20.14 | $258.97M | Pro | Pro |
 BK Technologies Corporation | $68.64 | $258.71M | Pro | Pro |
 Terra Innovatum Global N.V. Ordinary shares | $2.33 | $256.36M | Pro | Pro |
 Anika Therapeutics, Inc. | $19.09 | $255.48M | Pro | Pro |
 The E.W. Scripps Company | $2.76 | $255.3M | Pro | Pro |
 Cypherpunk Technologies Inc. | $2.59 | $254.32M | Pro | Pro |
 Lineage Cell Therapeutics, Inc. | $1.01 | $254.17M | Pro | Pro |
 Pure Cycle Corporation | $10.53 | $254.03M | Pro | Pro |
 Lexeo Therapeutics, Inc. Common Stock | $3.08 | $251.19M | Pro | Pro |
 Ocugen, Inc. | $0.7421 | $251.11M | Pro | Pro |
 SEACOR Marine Holdings Inc. | $9.20 | $250.6M | Pro | Pro |
 RCM Technologies, Inc. | $35.20 | $250.4M | Pro | Pro |
 Profound Medical Corp. | $6.80 | $248.24M | Pro | Pro |
 Arqit Quantum Inc. Ordinary Shares | $14.91 | $247.98M | Pro | Pro |
 OraSure Technologies, Inc. | $3.59 | $247.33M | Pro | Pro |
 Coincheck Group N.V. Ordinary Shares | $1.29 | $247.1M | Pro | Pro |
 Barrel Energy, Inc. | $0.27 | $245.97M | Pro | Pro |
 CAMP4 Therapeutics Corporation | $3.92 | $245.68M | Pro | Pro |
 Fate Therapeutics, Inc. | $2.06 | $245.03M | Pro | Pro |
 Energys Group Limited Ordinary Shares | $4.49 | $244.88M | Pro | Pro |
 Lifecore Biomedical, Inc. | $6.42 | $243.55M | Pro | Pro |
 Oatly Group AB American Depositary Shares | $7.59 | $243.33M | Pro | Pro |
 Abeona Therapeutics Inc. | $4.28 | $243.32M | Pro | Pro |
 Perma-Pipe International Holdings, Inc. | $29.57 | $243.19M | Pro | Pro |
 Alta Equipment Group Inc. | $7.46 | $243.04M | Pro | Pro |
 Cabaletta Bio, Inc. | $1.44 | $242.45M | Pro | Pro |
 BRC Inc. | $9.64 | $241.53M | Pro | Pro |
 Standard BioTools Inc. | $0.6113 | $241.29M | Pro | Pro |
 Global Water Resources, Inc. | $8.06 | $241.1M | Pro | Pro |
 RGC Resources, Inc. | $23.10 | $240.69M | Pro | Pro |
 Community Bancorp | $42.90 | $240.28M | Pro | Pro |
 BRT Apartments Corp. | $12.74 | $239.49M | Pro | Pro |
 InflaRx N.V. Common Stock | $1.63 | $239.47M | Pro | Pro |
 Greenwich LifeSciences, Inc. | $16.26 | $238.67M | Pro | Pro |
51-100 of 1,865 companies
Rank every covered company by dilution risk, potential new shares and cash runway with Signal8 Pro.
Unlock with Pro · $59/mo$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)